Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduxin Forte vs Reduxin in Alimentary Obesity
NCT05821543Phase 4Completed
- Sponsor
- Promomed
- Start
- Jul 2020
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Reduxin Forte in obesity, sponsored by Promomed. Started Jul 2020; status: completed.
02
Drugs
Reduxin Forte
03
Conditions
obesity
Beyond the preview
Go deeper on NCT05821543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05821543.